NYSTATIN AND TRIAMCINOLONE ACETONIDE Drug Patent Profile
✉ Email this page to a colleague
When do Nystatin And Triamcinolone Acetonide patents expire, and what generic alternatives are available?
Nystatin And Triamcinolone Acetonide is a drug marketed by Alembic, Alpharma Us Pharms, Amneal, Crown Labs Inc, Dr Reddys, Fougera Pharms Inc, Glenmark Pharms Ltd, Lupin Ltd, Macleods Pharms Ltd, Padagis Israel, Perrigo New York, Pharmafair, Taro, Torrent, Chartwell Rx, Epic Pharma Llc, Pai Holdings Pharm, Rising, Strides Pharma, and Zydus Lifesciences. and is included in thirty-one NDAs.
The generic ingredient in NYSTATIN AND TRIAMCINOLONE ACETONIDE is nystatin; triamcinolone acetonide. There are eight drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nystatin And Triamcinolone Acetonide
A generic version of NYSTATIN AND TRIAMCINOLONE ACETONIDE was approved as nystatin; triamcinolone acetonide by FOUGERA PHARMS INC on October 8th, 1985.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NYSTATIN AND TRIAMCINOLONE ACETONIDE?
- What are the global sales for NYSTATIN AND TRIAMCINOLONE ACETONIDE?
- What is Average Wholesale Price for NYSTATIN AND TRIAMCINOLONE ACETONIDE?
Summary for NYSTATIN AND TRIAMCINOLONE ACETONIDE
| US Patents: | 0 |
| Applicants: | 20 |
| NDAs: | 31 |
| Finished Product Suppliers / Packagers: | 22 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | NYSTATIN AND TRIAMCINOLONE ACETONIDE at DailyMed |
Pharmacology for NYSTATIN AND TRIAMCINOLONE ACETONIDE
| Drug Class | Corticosteroid Polyene Antifungal |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for NYSTATIN AND TRIAMCINOLONE ACETONIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rising | NYSTATIN AND TRIAMCINOLONE ACETONIDE | nystatin; triamcinolone acetonide | OINTMENT;TOPICAL | 206785-001 | Dec 29, 2016 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Strides Pharma | NYSTATIN AND TRIAMCINOLONE ACETONIDE | nystatin; triamcinolone acetonide | OINTMENT;TOPICAL | 210077-001 | Jan 29, 2018 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Alembic | NYSTATIN AND TRIAMCINOLONE ACETONIDE | nystatin; triamcinolone acetonide | CREAM;TOPICAL | 214090-001 | Mar 31, 2021 | AT | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
